Abstract
Objective Telemedicine has advanced to the forefront of healthcare delivery, including maternal-fetal medicine. Smart wearable electrocardiogram (ECG) devices can enable pregnant women to monitor their health and that of their fetuses. Such technology would be a logical extension of the telemedicine ecosystem. However, it is not known how pregnant women perceive the ability to use such technologies.
Design Observational cross-sectional study.
Setting Online survey in the United States in 2019.
Population A representative sample of 507 women aged 18-45 were polled from 45 states.
Methods Study participants were recruited using the SurveyMonkey Audience Polling system and responded virtually.
Main Outcome Measures Women were asked to identify willingness to use a wearable ECG device the size of a patch-sized large band-aid on their abdomen. Ten binary or multiple-choice questions were used to gauge population interest and related demographics towards the usage of a wearable ECG device.
Results 91% of women expecting to become pregnant in the next five years accept wearable ECG technology as a mechanism for increased frequency of monitoring of maternal and fetal health throughout the pregnancy outside the hospital. 78% of women demonstrated a willingness to wear devices day and night or at least during sleep and 42% of women would spend up to $200 on such a device.
Conclusions Even though conducted prior to the COVID-19 pandemic, this study clearly indicates a high degree of readiness of prospective pregnant women for telemedicine with continuous health monitoring of the mother-fetus dyad during the entire antepartum period.
Funding n/a
Competing Interest Statement
The study was conducted as part of a research project by Fetal Precision LLC. The company has been since dissolved and the findings have been open sourced. M. G. Frasch has patents on aECG (WO2018160890) and EEG technologies for fetal monitoring (US9215999). The authors declare that the research was conducted in the absence of any other commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Washington Human Subjects Division Institutional Review Board Due to the completely anonymous nature of the data collection and the provided right to opt out of the survey or agree to continue, no IRB approval was obtained prior to the survey's completion. However, after the completion of the survey and prior to publication of the findings, we consulted the UW IRB. It was determined that the approach taken meets the definition of "minor non-compliance" with IRB-approved procedures/UW policies and procedures, because it posed no significant increase in risk or any decrease in benefits to subjects. The IRB ruled that this means that the data collected as part of this research cannot be described as part of a study reviewed by human subject division (IRB). On January 24, 2022, the IRB determined that the corrective actions described in the report are sufficient. No additional actions are required at this time.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.